Search for: "Hoffman-LaRoche, Inc." Results 41 - 58 of 58
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2009, 5:18 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 814 (5th Cir. 1992) (no presumption in unavoidably unsafe products because the effect of a presumption on an inherent risk would be to presume that nobody would ever use the product); Lineberger v. [read post]
15 May 2010, 2:22 pm
"'[T]he types of conduct which can form a basis for finding a case exceptional [include] . . . inequitable conduct before the P.T.O., [and] misconduct during litigation.'" Hoffman-LaRoche, Inc. v. [read post]
27 Feb 2014, 6:00 am
            We watched some of the recently concluded Winter Olympics. [read post]
9 Jan 2014, 1:37 pm
Hoffman-La Roche, Inc., 2010 WL 3034453, at *22 (N.J. [read post]
24 May 2007, 10:40 am
Hoffman-LaRoche, Inc., 949 F.2d 806, 816 (5th Cir. 1992) (applying Mississippi law). [read post]
19 Nov 2009, 10:51 am by Beck/Herrmann
Hoffman LaRoche, Inc., 917 A.2d 767 (N.J. 2007) (which we reviewed here), the court held that in personal injury actions, the individual plaintiff's home state/place where the injury occurred should control: [H]aving considered the contacts relevant to the competing interests of the states in light of Rowe, this Court concludes that the competing interests of the states, the most important factor, weighs in favor of applying the law of each plaintiff's home… [read post]
2 Oct 2008, 12:36 pm
Hoffman-LaRoche, Inc., 949 F.2d 806, 812 (5th Cir.1992) ("to create a jury question, the evidence introduced must be of sufficient weight to establish. . .some reasonable likelihood that an adequate warning would have prevented the plaintiff from receiving the drug") (applying Mississippi law); Demmler v. [read post]
11 May 2011, 5:28 pm by Michael O'Brien
Hoffman-LaRoche, Inc., which departed from all existing case law at that moment.[22]  In Molecular Diagnostics, the plaintiff, a direct purchaser of the subject patented product, brought suit under Section 1 of the Sherman Act charging that it had been forced to pay artificially inflated prices for the product as a result of defendants' enforcement of the patent, which plaintiffs allege was obtained by fraud on the PTO. [read post]
8 May 2008, 12:22 pm
Hoffman-LaRoche, Inc., 949 F.2d 806 (5th Cir. 1992). [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
2 May 2008, 7:00 am
: (Patent Baristas), US: How to avoid a permanent injunction: the lessons of Amgen v Hoffman-LaRoche: (Patent Docs), US: Jarvik Heart’s PTE request based on PMA shell/module submission dates flatlines; ruling on initiation of PTE ‘review period’ mirrors FDA policy for ‘fast track’ products: (FDA Law Blog) Pharma & Biotech - Products Kytril (Granisetron) – Exclusivity ‘parking’… [read post]